Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial

Dan Ziegler, Phillip A. Low, Roy Freeman, Hans Tritschler, Aaron I. Vinik

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Fingerprint Dive into the research topics of 'Predictors of improvement and progression of diabetic polyneuropathy following treatment with α-lipoic acid for 4 years in the NATHAN 1 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences